RLMD
Relmada Therapeutics Inc
Price:  
0.37 
USD
Volume:  
858,803.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLMD WACC - Weighted Average Cost of Capital

The WACC of Relmada Therapeutics Inc (RLMD) is 7.2%.

The Cost of Equity of Relmada Therapeutics Inc (RLMD) is 10.70%.
The Cost of Debt of Relmada Therapeutics Inc (RLMD) is 5.00%.

Range Selected
Cost of equity 9.20% - 12.20% 10.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.5% - 7.9% 7.2%
WACC

RLMD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.17 1.32
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.20% 12.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.5% 7.9%
Selected WACC 7.2%